[go: up one dir, main page]

AU2001280109A1 - A method of producing fr901228 - Google Patents

A method of producing fr901228

Info

Publication number
AU2001280109A1
AU2001280109A1 AU2001280109A AU8010901A AU2001280109A1 AU 2001280109 A1 AU2001280109 A1 AU 2001280109A1 AU 2001280109 A AU2001280109 A AU 2001280109A AU 8010901 A AU8010901 A AU 8010901A AU 2001280109 A1 AU2001280109 A1 AU 2001280109A1
Authority
AU
Australia
Prior art keywords
producing
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU2001280109A
Inventor
Tomoji Higaki
Munekazu Kanda
Mitsunori Matsuda
Masaru Tsuboi
Satoshi Ueda
Yoko Watamoto
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Fujisawa Pharmaceutical Co Ltd
Original Assignee
Fujisawa Pharmaceutical Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=18752685&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=AU2001280109(A1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Fujisawa Pharmaceutical Co Ltd filed Critical Fujisawa Pharmaceutical Co Ltd
Publication of AU2001280109A1 publication Critical patent/AU2001280109A1/en
Abandoned legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P21/00—Preparation of peptides or proteins
    • C12P21/02—Preparation of peptides or proteins having a known sequence of two or more amino acids, e.g. glutathione
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/10—Tetrapeptides
    • C07K5/1002—Tetrapeptides with the first amino acid being neutral
    • C07K5/1005—Tetrapeptides with the first amino acid being neutral and aliphatic
    • C07K5/101—Tetrapeptides with the first amino acid being neutral and aliphatic the side chain containing 2 to 4 carbon atoms, e.g. Val, Ile, Leu
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Biochemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Molecular Biology (AREA)
  • Genetics & Genomics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Engineering & Computer Science (AREA)
  • Biophysics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Biotechnology (AREA)
  • Microbiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Engineering & Computer Science (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
AU2001280109A 2000-09-01 2001-08-22 A method of producing fr901228 Abandoned AU2001280109A1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
JP2000-265414 2000-09-01
JP2000265414 2000-09-01
PCT/JP2001/007191 WO2002020817A1 (en) 2000-09-01 2001-08-22 A method of producing fr901228

Publications (1)

Publication Number Publication Date
AU2001280109A1 true AU2001280109A1 (en) 2002-03-22

Family

ID=18752685

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2001280109A Abandoned AU2001280109A1 (en) 2000-09-01 2001-08-22 A method of producing fr901228

Country Status (6)

Country Link
US (10) US7396665B2 (en)
EP (1) EP1313872A1 (en)
JP (1) JP2004508049A (en)
AR (1) AR030714A1 (en)
AU (1) AU2001280109A1 (en)
WO (1) WO2002020817A1 (en)

Families Citing this family (34)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1313872A1 (en) 2000-09-01 2003-05-28 Fujisawa Pharmaceutical Co., Ltd. A method of producing fr901228
US7951780B2 (en) 2004-02-25 2011-05-31 Astellas Pharma Inc. Antitumor agent
WO2007061939A2 (en) * 2005-11-18 2007-05-31 Gloucester Pharmaceuticals, Inc. Metabolite derivatives of the hdac inhibitor fk228
CA2650520A1 (en) 2006-04-24 2008-01-31 Gloucester Pharmaceuticals Treatment of ras-expressing tumors
WO2007146730A2 (en) 2006-06-08 2007-12-21 Gloucester Pharmaceuticals Deacetylase inhibitor therapy
WO2008083290A1 (en) * 2006-12-29 2008-07-10 Gloucester Pharmaceuticals, Inc. Romidepsin-based treatments for cancer
AU2007342028B2 (en) * 2006-12-29 2013-06-13 Celgene Corporation Purifiction of romidepsin
WO2008098199A2 (en) * 2007-02-08 2008-08-14 Uwm Research Foundation, Inc. Sequences for fk228 biosyntnesis and methods of synthesizing fk228 and fk228 analogs
US20110060021A1 (en) * 2009-08-19 2011-03-10 Yiqiang Cheng Histone deacetylase inhibitors and uses thereof
US9526251B2 (en) 2010-02-25 2016-12-27 Marrone Bio Innovations, Inc. Use of Burkholderia formulations, compositions and compounds to modulate crop yield and/or corn rootworm infestation
US8822193B2 (en) 2010-02-25 2014-09-02 Marrone Bio Innovations, Inc. Isolated bacterial strain of the genus Burkholderia and pesticidal metabolites therefrom
AR080234A1 (en) * 2010-02-25 2012-03-21 Marrone Bio Innovations Inc BACTERIAL CEPA ISOLATED FROM THE BURKHOLDERIA AND METABOLITES PESTICIDES OF THE SAME
MX342913B (en) 2010-07-12 2016-10-19 Celgene Corp * Romidepsin solid forms and uses thereof.
AU2015202335B2 (en) * 2010-07-12 2017-02-02 Celgene Corporation Romidepsin solid forms and uses thereof
US8859502B2 (en) 2010-09-13 2014-10-14 Celgene Corporation Therapy for MLL-rearranged leukemia
HK1200330A1 (en) 2011-09-23 2015-08-07 细胞基因公司 Romidepsin and 5 - azacitidine for use in treating lymphoma
WO2013049093A1 (en) 2011-09-26 2013-04-04 Celgene Corporation Combination therapy for chemoresistant cancers
WO2013085902A1 (en) 2011-12-05 2013-06-13 The University Of Texas M.D. Combination therapy methods for treating an inflammatory breast cancer
JP6170946B2 (en) 2012-01-12 2017-07-26 セルジーン コーポレイション Romidepsin preparation and use thereof
AU2013202506B2 (en) 2012-09-07 2015-06-18 Celgene Corporation Resistance biomarkers for hdac inhibitors
US9119401B2 (en) 2012-10-19 2015-09-01 Marrone Bio Innovations, Inc. Plant glutamine synthetase inhibitors and methods for their identification
AU2013202507B9 (en) 2012-11-14 2015-08-13 Celgene Corporation Inhibition of drug resistant cancer cells
US9006462B2 (en) 2013-02-28 2015-04-14 Dermira, Inc. Glycopyrrolate salts
US8558008B2 (en) 2013-02-28 2013-10-15 Dermira, Inc. Crystalline glycopyrrolate tosylate
SG11201506789PA (en) 2013-02-28 2015-09-29 Dermira Inc Glycopyrrolate salts
NZ630311A (en) 2013-12-27 2016-03-31 Celgene Corp Romidepsin formulations and uses thereof
IN2014MU00740A (en) * 2014-03-04 2015-09-25 Concord Biotech Ltd
CN104262456B (en) * 2014-09-11 2018-01-09 浙江海正药业股份有限公司 A kind of novel crystal forms of romidepsin and its production and use
EP3313420B1 (en) 2015-06-25 2024-03-13 The Children's Medical Center Corporation Methods and compositions relating to hematopoietic stem cell expansion, enrichment, and maintenance
US20190119642A1 (en) 2016-03-15 2019-04-25 Children's Medical Center Corporation Methods and compositions relating to hematopoietic stem cell expansion
CN105801667B (en) * 2016-03-22 2019-04-09 浙江海正药业股份有限公司 A method of preparing unformed romidepsin
CN109796521B (en) * 2017-11-17 2022-04-19 上海医药工业研究院 Romidepsin acetate crystal form and preparation method thereof
EP3902908A4 (en) * 2018-12-24 2024-01-03 Pro Farm Group, Inc. METHOD FOR INCREASING PRODUCTION OF ROMIDEPSIN FROM A FERMENTATION BROTH
AR129181A1 (en) 2022-04-28 2024-07-24 Pro Farm Group Inc METHOD FOR INHIBITING THE EMERGENCY AND/OR GROWTH OF MONOCOTYLEDONOUS WEEDS, SEDGIES AND DICOTYLEDONOUS WEEDS, AND SYNERGIC HERBICIDE COMPOSITION USABLE THEREIN

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB8817743D0 (en) 1988-07-26 1988-09-01 Fujisawa Pharmaceutical Co Fr901228 substance & preparation thereof
JP2936663B2 (en) * 1990-07-24 1999-08-23 藤沢薬品工業株式会社 Method for producing FR901228 substance
US5595756A (en) * 1993-12-22 1997-01-21 Inex Pharmaceuticals Corporation Liposomal compositions for enhanced retention of bioactive agents
PT1438966E (en) 1999-12-08 2007-05-31 Cyclacel Pharmaceuticals Inc Use of depsipeptide and congeners thereof as immunosuppressants for treating an infectious disease, an autoimmune disease, allergic reactions or a hyperproliferative skin disease.
JP4810784B2 (en) 2000-07-17 2011-11-09 アステラス製薬株式会社 Reduced FK228 and uses thereof
EP1313872A1 (en) 2000-09-01 2003-05-28 Fujisawa Pharmaceutical Co., Ltd. A method of producing fr901228

Also Published As

Publication number Publication date
US9371361B2 (en) 2016-06-21
US20120225829A1 (en) 2012-09-06
US20080227975A1 (en) 2008-09-18
US20160273016A1 (en) 2016-09-22
US20030186388A1 (en) 2003-10-02
US7396665B2 (en) 2008-07-08
US7611724B2 (en) 2009-11-03
US8445634B2 (en) 2013-05-21
EP1313872A1 (en) 2003-05-28
WO2002020817A1 (en) 2002-03-14
US20150225453A1 (en) 2015-08-13
US7608280B2 (en) 2009-10-27
US8426556B2 (en) 2013-04-23
US20090264617A1 (en) 2009-10-22
US20090156785A1 (en) 2009-06-18
AR030714A1 (en) 2003-09-03
JP2004508049A (en) 2004-03-18
US20130225507A1 (en) 2013-08-29
US20120225830A1 (en) 2012-09-06
US20090264343A1 (en) 2009-10-22

Similar Documents

Publication Publication Date Title
AU2001280109A1 (en) A method of producing fr901228
AU2001285406A1 (en) Method of interactively profiling a structure
AU2002216986A1 (en) Method of making a can having a recessed base
AUPQ687600A0 (en) A method of detection
AU2001264134A1 (en) Microconnectors and method for their production
AU2001271150A1 (en) A method of communication
AU2001291882A1 (en) Method for producing polyisobutylphenols
AU2001246964A1 (en) Method of manufacturing hydrogen
AU4235001A (en) Laminate and process for producing a laminate of this type
AU2002231683A1 (en) Method of producing alk-3-ene-1-ols
AU2002214183A1 (en) Method of making a finished product
AU2001272757A1 (en) Process for producing 5-fluorooxyindole and for producing intermediate therefor
AUPQ835400A0 (en) A method of mining
AU2002211632A1 (en) Method of making a polycarbonate blend
AU2002212224A1 (en) Method for producing delta1-pyrrolines
AU2001244717A1 (en) Method of producing a hologram
AU2002221735A1 (en) Method of manufacturing a lamp
AU2001262147A1 (en) Method for producing 4-bromo- and 4-chloro-2-nitro-1-trifluoromethoxybenzene
AU2000255927A1 (en) A method of making paper
AU2002217463A1 (en) Process for producing allumium extracts
AUPQ680300A0 (en) A method
AUPQ781100A0 (en) A method of detection
AU2001276577A1 (en) Method of making a composite panel
AUPQ646600A0 (en) A method of screening
AU2001286268A1 (en) Method of forming complex